(Q34421501)

2 August 2017

1 reference

title

Molecular mechanisms of renal allograft fibrosis (English)

1 reference

2 August 2017

Waller JR

1

1 reference

2 August 2017

Nicholson ML

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

British Journal of Surgery

2 August 2017

published in

1 reference

2 August 2017

volume

88

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

1429-1441

1 reference

Chronic allograft nephropathy-a model of impaired repair from injury?

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Effector mechanisms in allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Extracellular matrix and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Metalloproteinases and their inhibitors in matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Human recombinant interleukin-1 alpha increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Human progelatinase A can be activated by matrilysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Tissue inhibitors of matrix metalloendopeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Extracellular matrix accumulation in immune-mediated tubulointerstitial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Relaxin: a pleiotropic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Motifs resembling hepatocyte nuclear factor 1 and activator protein 3 mediate the tissue specificity of the human plasminogen gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Effects of explosive brain death on cytokine activation of peripheral organs in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Late-acute renal allograft rejection and symptomless cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Secretory products of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Fibroblasts, myofibroblasts, and wound contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Identification and characterization of a fibroblast marker: FSP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Involvement of S100-related calcium-binding protein pEL98 (or mts1) in cell motility and tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Interleukin 1: the first interleukin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Interleukin 6 is an autocrine growth factor for mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Macrophage activation by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Role of basic fibroblast growth factor in vascular lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Transforming growth factor-beta in disease: the dark side of tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Transforming growth factor-beta: recent progress and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Latent transforming growth factor-beta: structural features and mechanisms of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

TGF-beta in kidney fibrosis: a target for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Transforming growth factor-beta regulates production of proteoglycans by mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Sodium-lithium countertransport: physiology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Angiotensin II type 2 receptor mediates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.01867.X

10.1046/J.0007-1323.2001.01867.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference